Photo by Jenn_Jenn. Licensed under Creative Commons license 2.0.
According to this tiny news posting, the cellulosic ethanol biotech team over at Coskata has raised $19.5 million in Series B funding (series B funds are made in the second round of investment in a private company). Whether that money includes the undisclosed amount GM put into the company earlier this year is unclear. I went hunting for the original regulatory filing where Private Equity HUB claims they found the information, but couldn't track it down. Coskata has not yet released an official statement about the funding, but PE says that backers named in the filing include Globespan Capital Partners, General Motors, Khosla Ventures, GreatPoint Ventures and Advanced Technology Ventures. The new name in the Coskata-backing lineup is Globespan.
[Source: Private Equity HUB]
According to this tiny news posting, the cellulosic ethanol biotech team over at Coskata has raised $19.5 million in Series B funding (series B funds are made in the second round of investment in a private company). Whether that money includes the undisclosed amount GM put into the company earlier this year is unclear. I went hunting for the original regulatory filing where Private Equity HUB claims they found the information, but couldn't track it down. Coskata has not yet released an official statement about the funding, but PE says that backers named in the filing include Globespan Capital Partners, General Motors, Khosla Ventures, GreatPoint Ventures and Advanced Technology Ventures. The new name in the Coskata-backing lineup is Globespan.
[Source: Private Equity HUB]
Sign in to post
Please sign in to leave a comment.
Continue